Skip to main content

Table 4 The formula of established prediction methods for significant fibrosis, advanced fibrosis and cirrhosis

From: Cytokeratin 18 can help predict liver fibrosis in HCV infected patients with type 2 diabetes mellitus

 

Significant fibrosis (F0-1 vs F2-4)

Advanced fibrosis (F0-2 vs F3-4)

Cirrhosis (F0-3 vs F4)

TE + CK18

0.945*TE + 1.252*CK18 − 6.765

1.003*TE + 0.335*CK18 − 9.157

0.465*TE + 0.576*CK18 − 6.903

APRI + CK18

0.399*APRI + 1.858*CK18 − 0.680

− 0.022*APRI + 1.164*CK18 − 0.987

− 0.006*APRI + 1.175*CK18 − 2.137

FIB-4 + CK18

0.331*FIB-4 + 1.823*CK18 − 0.894

0.227*FIB-4 + 1.133*CK18 − 1.452

0.442*FIB-4 + 1.226*CK18 − 3.228

  1. Numbers in parentheses are the 95% confidence interval
  2. AUROC, area under the receiver operating characteristic; APRI, aspartate transaminase-to-platelet ratio; CK18, cytokeratin 18; FIB-4, fibrosis-4 index; TE, transient elastography
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us